Announces, European

mAbxience Announces European Commission Approval of Denosumab Biosimilars

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

mAbxience Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

en | boerse | 67928153 |